Cat Dementia Research Is Helping Scientists Understand Human Alzheimer's

Research published through the University of Edinburgh has found that cats with feline cognitive dysfunction syndrome (FCD) — sometimes called cat dementia — develop a buildup of amyloid-beta protein at brain synapses that closely mirrors changes seen in early-stage human Alzheimer's disease. Because cats develop the condition naturally while sharing many environmental exposures with their owners, researchers say they may offer a uniquely useful model for studying the human disease.

FCD is increasingly recognized as common in aging cats. A cited survey found that 28 percent of cats aged 11 to 14 show at least one clinical sign of the condition, rising to 50 percent in cats over 15. Separate ASPCA estimates put the figure even higher for the oldest cats: more than 80 percent of cats aged 16 to 20 show some sign of cognitive decline.

Common signs include disorientation, altered social interaction, changes to sleep-wake cycles, increased nighttime vocalization, and house soiling in previously reliable cats — all of which can also result from pain, hyperthyroidism, or hypertension, making veterinary rule-out essential before assuming cognitive decline is the cause.

There is currently no approved treatment or cure for FCD in cats, though researchers note that dietary antioxidant support and environmental stability have shown promise in slowing symptom progression when used alongside veterinary management.

Owners noticing new nighttime vocalization or disorientation in a senior cat can read our full breakdown of cognitive decline versus normal aging in senior cats.

Sources

• ScienceDaily — How cats with dementia could help crack the Alzheimer's puzzle
• PMC — Amyloid-Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome
• ASPCA — Older Cats with Behavior Problems